Commentary on: Cost-effectiveness of pneumococcal vaccination and of programs to increase its uptake in U.S. older adults.

J Am Geriatr Soc

Department of Medicine (Geriatrics), Dalhousie University, Halifax, Nova Scotia, Canada.

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.19079DOI Listing

Publication Analysis

Top Keywords

commentary cost-effectiveness
4
cost-effectiveness pneumococcal
4
pneumococcal vaccination
4
vaccination programs
4
programs increase
4
increase uptake
4
uptake older
4
older adults
4
commentary
1
pneumococcal
1

Similar Publications

This letter discusses the recent study by Vahabi et al., which examined the role of preoperative cardiology consultations in geriatric patients undergoing hip fracture surgery. While the study highlights the limited impact of these consultations on treatment modifications and the associated delays in surgical intervention, this letter suggests areas for further exploration.

View Article and Find Full Text PDF

Our commentary proposes the application of directed acyclic graphs (DAGs) in the design of decision-analytic models, offering researchers a valuable and structured tool to enhance transparency and accuracy by bridging the gap between causal inference and model design in medical decision making.The practical examples in this article showcase the transformative effect DAGs can have on model structure, parameter selection, and the resulting conclusions on effectiveness and cost-effectiveness.This methodological article invites a broader conversation on decision-modeling choices grounded in causal assumptions.

View Article and Find Full Text PDF

Background: In their interesting systematic review, Gallehzan et al. quoted our article Cost-utility analysis of teriflunomide in naïve vs. previously treated patients with relapsing-remitting multiple sclerosis (RRMS) in Italy.

View Article and Find Full Text PDF

Mentoring for the Diverse Range of Family Physicians' Engagement in Research.

J Am Board Fam Med

December 2024

From the Department of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado (MLM); Department of Family Medicine, Indiana University School of Medicine, Indianapolis, IN (MS); Department of Family and Community Medicine, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND (DFS); Department of Family and Community Medicine, McGovern Medical School, University of Texas Houston, Houston, TX (NJR).

Primary care researchers are increasingly at the forefront of developing innovations and new research methods to address complex issues in health care, including multi-morbidity, social determinants of health, health equity, managing population health in clinical practice, patient satisfaction, and provider burnout. Research demonstrates that "primary care is the only health care component where an increased supply is associated with better population health and more equitable outcomes." As a primary care specialty, family medicine has evolved beyond its initial focus on clinical practice and education to realizing the imperative for the discipline to robustly engage in research and embrace the responsibility to generate the evidence that drives changes in primary care practice and policy.

View Article and Find Full Text PDF

Exploring opposing arguments in the call for randomized controlled trials to demonstrate benefit of Mohs micrographic surgery for cutaneous melanoma.

Dermatol Online J

October 2024

Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Article Synopsis
  • The lack of robust randomized clinical trials (RCTs) comparing Mohs micrographic surgery (MMS) to wide local excision for melanoma treatment is hindering the establishment of clinical guidelines, despite evidence that supports MMS's benefits.
  • There is ongoing debate about the necessity of RCTs in dermatologic surgery, with some arguing that the existing retrospective studies and meta-analyses already provide sufficient evidence for MMS's efficacy and cost-effectiveness.
  • The absence of clear guidelines has led to confusion among healthcare providers and disparities in access to melanoma treatments across different specialties.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!